3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
95
Breast Neoplasms, Male
6
Advanced Breast Cancer
4
Triple Negative Breast Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Infertility
2
Sexual Dysfunctions, Psychological
1
Primary Ovarian Insufficiency
1
Patient Compliance
1
Osteitis Deformans
1
Inflammatory Breast Neoplasms
1
Hyperlipidemias
1
Hormone-sensitive Metastatic Breast Cancer
1
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
HER2-positive Breast Cancer
1
HER2 Negative Breast Cancer
1
Breast Diseases
1
Breast Cancer Invasive
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Metastatic Breast Cancer
1
Interventions
vistusertib
1
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Metastatic Breast Cancer
×
Goserelin
×
Breast
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA